Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Fasting Recommendations on Residual Gastric Contents Among Patients Using Glucagon-like Peptide-1 Receptor Agonists: A Randomised Controlled Trial

NCT06839248 is registered in ClinicalTrials.gov with St Vincent's Hospital Melbourne as lead sponsor.

NCT NCT06839248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06839248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Fasting Recommendations on Residual Gastric Contents Among Patients Using Glucagon-like Peptide-1 Receptor Agonists: A Randomised Controlled Trial
Lead sponsor
St Vincent's Hospital Melbourne
Phase
Not applicable
Overall status
Recruiting
Start date
June 20, 2025
Completion date
February 1, 2027
Enrollment
154 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary aspiration of gastric contents, residual gastric contents